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1. Introduction 
Tick-borne encephalitis virus (TBEV) belongs to the genus Flavivirus in the family 
Flaviviridae. TBEV is transmitted through the bite of an infected tick and causes acute central 
nervous system (CNS) disease in humans (Dumpis, Crook, and Oksi, 1999; Lindquist and 
Vapalahti, 2008). TBEV is prevalent over a wide area of Europe and Asia, and is 
geographically and genetically divided into three subtypes, the European, Siberian and far 
eastern subtypes (Ecker et al., 1999; Hayasaka et al., 2001b). The endemic areas of Europe 
and Asia correspond to the geographical distribution of Ixodes tick species (Burke and 
Monath, 2001; Dumpis, Crook, and Oksi, 1999). 
Tick-borne encephalitis (TBE) cases exhibit neurological symptoms including fever, 
headache, meningitis, meningoencephalitis and meningoencephalomyelitis, the latter being 
evident in the most severe cases (Dumpis, Crook, and Oksi, 1999). These non-specific clinical 
features of TBE may be due to widespread occurrence of neuronal dysfunction at different 
sites in the CNS. Hence, laboratory diagnosis is required to distinguish TBE from other 
neurological disorders (Charrel et al., 2004; Holzmann, 2003). 
The laboratory mouse model is commonly employed to elucidate the mechanism of disease 
development following TBEV infection in vivo. The pathogenetic process following 
experimental infection with TBEV is fundamentally similar to that of other encephalitic 
flaviviruses including Japanese encephalitis virus (JEV), West Nile virus (WNV) and Murray 
Valley encephalitis virus (MVEV) (Albrecht, 1968; Burke and Monath, 2001; Garcia-Tapia et 
al., 2007). In the mouse model, the CNS pathology of TBEV and other encephalitic 
flaviviruses consists of two distinct features: neuroinvasiveness and neurovirulence. It is 
generally considered that death following peripheral infection represents 
neuroinvasiveness, whereas mortality following direct intracerebral infection represents 
neurovirulence (Mandl, 2005; Monath, 1986). 
Recent works have proposed that CNS pathology following TBEV infection is a consequence 
of viral infection of the corresponding cells and the resulting inflammatory response. Direct 
viral infection of neurons is considered to be the major cause of neurological disease because 
viral infections cause apoptosis or degeneration of neurons in vivo and in vitro (Couderc et al., 
2002; Liao et al., 1997; Prikhod'ko et al., 2001; Shrestha, Gottlieb, and Diamond, 2003). In 
addition, recent studies have demonstrated that immunopathological effects also contribute to 
the severity of CNS pathology (Hayasaka et al., 2009; Ruzek et al., 2009; Wang et al., 2003). 
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In this chapter, we discuss the multiple mechanisms of disease development observed in a 
mouse model following peripheral and intracerebral infection with TBEV. 
2. Experimental infection in mice 
2.1 Peripheral infection 
Peripheral infection such as subcutaneous, foot-pad or intradermal route is considered to be 
a replica of natural infection resulting from the bite of an infected tick. From studies of 
encephalitic flavivirus infections, it is believed that initial virus replication occurs in 
dendritic cells (DCs) such as Langerhans cells at the site of infection, and infected DCs 
migrate to draining lymph nodes. After viremia and replication in peripheral organs, the 
virus invades the CNS and the host develops CNS disease, although the mechanism by 
which the blood-brain-barrier is crossed is not completely understood (Byrne et al., 2001; 
Dumpis, Crook, and Oksi, 1999; Robertson et al., 2009; Samuel and Diamond, 2006). Thus, 
peripheral infection is generally regarded as a model for neuroinvasiveness. 
Following subcutaneous infection with low challenge dose (103 PFU) of TBEV, infectious 
virus is first detected in peripheral organs such as blood, spleen, thymus, lung (Hayasaka et 
al., 2009), liver and kidney (Hayasaka et al., unpublished data) at 1 to 3 days post-infection 
(p.i.), and subsequently appears in the CNS at 5 to 7 days p.i.. However, virus replication in 
peripheral organs does not appear to correlate with the progression of disease, because mice 
did not have apparent clinical signs during the peak stages of infectious virus in peripheral 
organs (Hayasaka et al., 2009).  
2.2 Intracerebral infection 
Intracerebral infection is commonly performed to examine direct neuronal virulence and 
pathogenicity in the CNS. Intracerebral infection usually results in high mortality rates, and 
50% lethal doses (LD50) are often below 1PFU (Chiba et al., 1999a; Monath et al., 1980). Thus, 
it is believed that the ensuing intracerebral infection and lethal encephalitis after viral entry 
into the CNS directly represent neurovirulence. 
We previously showed that following intracerebral infection with TBEV, virus replication 
occurred almost simultaneously in peripheral and CNS organs, and acute viral replication 
was observed throughout the CNS (Hayasaka et al., 2010). Thus, mortality following 
intracerebral infection is directly related to the severity of viral infection in the CNS 
(Hayasaka et al., 2010).  
2.3 Virus tropism within CNS 
Interestingly, virus tropism has been observed in the CNS following TBEV infection. After 
subcutaneous infection with low virus challenge doses of TBEV Oshima strain, the brain 
cortex or cerebellum was infected at early or late stage of infection, respectively (Hayasaka 
et al., 2009). In particular, disappearance of Purkinje cells was observed at late periods post-
infection. On the other hand, subcutaneous infection with high virus challenge doses 
resulted in acute and widespread neuronal infection without significant differences between 
the brain cortex, thalamus, cerebellum, brainstem and spinal cord (Hayasaka et al., 2009). 
This virus tropism of TBEV within the CNS is clearly distinguished from the tropism of 
other encephalitic flaviviruses, e.g. JEV infection, in which infectious virus is mainly 
detected in the brain cortex regardless of inoculation route and challenge dose (Hayasaka, 
unpublished data).  
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2.4 Mortality as an index of virulence and pathogenesis 
It has been generally accepted that CNS infection causes lethal encephalitis. Thus, death has 
been used as an index of pathogenesis, and mortality is considered as a measure of 
neuroinvasiveness or neurovirulence following peripheral or intracerebral infection, 
respectively. 50% lethal dose (LD50) is often determined to compare the virulence of 
different virus strains or the pathogenesis in different conditions of infection. 
However, the role of neuroinvasiveness in mortality is controversial because some mice 
recovered from illness with neuropathological sequelae following peripheral infection 
(Chiba et al., 1999a; Hayasaka et al., 2001b; Hayasaka et al., 1999). Thus, viral neuroinvasion 
following peripheral infection does not simply determine whether or not the mice will die; 
rather, mortality is determined after the development of CNS disease. In other words, the 
mechanism of mortality following peripheral infection differs from that of intracerebral 
infection. 
2.4.1 Dose-independent mortality 
LD50 is determined based on the correlation of increased challenge doses and increased 
mortality rates (Reed and Muench, 1938). However, with some strains of encephalitic 
flavivirus including TBEV, mice do not exhibit a normal dose response curve of mortality 
following peripheral infection. This phenomenon was first reported in the 1940’s (Lennette, 
1944), but the reason for these apparent discrepancies is not fully understood. 
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Fig. 1. Mortality rates following subcutaneous and intracerebral inoculation with serial 
challenge doses of TBEV IR strain 
Two patterns of dose-independent mortality are suggested based on our studies. In the first 
pattern, no increase in mortality rate was observed for low dose challenges, e.g. around 50% 
mortality between 102 to 106 PFU inoculations (Hayasaka et al., 2009). This phenomenon was 
observed following peripheral infection with the Oshima, KH and VL strains (Chiba et al., 
1999a; Hayasaka et al., 2001a; Hayasaka et al., 2001b; Hayasaka et al., 1999). All of the mice 
tested positive for TBEV-specific antibody in those challenge doses, indicating an infectious 
rate of 100% (Hayasaka, unpublished data). Furthermore, viral load in the CNS was not 
significantly different between 102 to 106 PFU challenge doses, and the level of infectious 
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viruses detected in the CNS of recovering mice were similar to dying mice (Hayasaka et al., 
2009). From these observations, we hypothesize that neuroinvasion following peripheral 
infection does not simply determine mortality, and dose independence is attributable to the 
outcome of viral infection and host response in peripheral and/or CNS tissues. Thus, 
elucidation of CNS pathology relating to disease severity and mortality could be an 
important approach to understand this pattern of dose-independent mortality. 
Another pattern of dose-independent mortality is characterized by a reduction in mortality 
rate (<100%) using challenge doses higher than 100% lethal dose. For example, 
subcutaneous infection with 103 PFU of IR strain induced 100% mortality, but 105 PFU 
challenge dose exhibited 80% mortality rate (Fig. 1). Interestingly, the surviving mice did 
not have apparent clinical signs such as weight reduction, suggesting that peripheral 
infection and/or viral invasion in the CNS might not have occurred. We speculate that at 
early stage of infection, several factors involving innate immunity contribute to this pattern 
of dose-independent mortality. 
2.4.2 Dose-dependent mortality 
Dose-dependent mortality, on the other hand, is typically observed in intracerebral infection 
with any TBEV strain. For example, intracerebral inoculation with the Oshima or IR strain 
resulted to dose-dependent mortality, with 100% mortality attainable using more than 101 
PFU (Hayasaka et al., 2010) (Fig. 1). 
Furthermore, peripheral infection with some strains such as Sofjin, IR and Hochosterviz 
showed essentially dose-dependent mortality, and LD50 could be determined (Chiba et al., 
1999a; Hayasaka et al., 2001a), although some dose-independent mortality was observed in 
challenge doses higher than 100%lethal dose, as described above (Fig. 1). 
3. Two distinct features of early and late mortality 
We recently showed that mice died either at early or late stages of infection after peripheral 
infection with the Oshima strain of TBEV (Hayasaka et al., 2009). Whether mice show early 
or late mortality is determined by the infectious route, virus strain and inoculation dose. 
Importantly, dose-dependent or dose-independent mortality is closely associated with early 
or late mortality, respectively. Thus, in order to understand dose-independent mortality, 
elucidating the mechanism of late mortality in particular is important. 
3.1 Early mortality 
3.1.1 Intracerebral inoculation 
Intracerebral inoculation of the Oshima strain in mice caused death starting at 7 days p.i., 
and most died within 10 days p.i. regardless of the challenge dose (Hayasaka et al., 2010). 
Early death was also observed following intracerebral inoculation with the IR strain (Fig. 2). 
Infected mice remained asymptomatic for 4 to 5 days, after which they acutely exhibited 
clinical signs including weight loss, slowness in movement, ataxia, piloerection and 
anorexia. Mice exhibited neurological signs of paralysis such as rigidity and flaccid paralysis 
from 7 days p.i., although some mice did not have apparent paralysis before death 
(Hayasaka et al., 2010). Survivals challenged with less than 101 PFU were IgG negative for 
TBEV antigen, indicating that only positively infected mice eventually die (Hayasaka et al., 
unpublished data). These results suggest that intracerebral infection directly correlates with 
mortality, and is characterized by early death. 
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Fig. 2. Daily survival rates following intracerebral and subcutaneous inoculation with serial 
challenge doses of TBEV IR strain 
3.1.2 Peripheral inoculation with highly virulent strains 
Following intraperitoneal inoculation with Sofjin and Hochosterwitz strains, which exhibit 
dose-dependent mortality, mice died early at 8-10 days (Chiba et al., 1999b). Subcutaneous 
infection with the IR strain also exhibited early death; mice began to die at 8 days p.i., and 
most died within 11 days p.i. (Fig. 2). These observations suggest that peripheral inoculation 
with these TBEV strains cause early mortality like intracerebral infection. 
3.1.3 Peripheral inoculation with high virus challenge dose 
Subcutaneous inoculation with high challenge dose (>107 PFU) of the Oshima strain resulted 
in early mortality at a rate of more than 80% (Hayasaka et al., 2009). Mice started to die at 8 
days p.i. and most mice died by 13-14 days p.i.. These infections elicited early onset of 
weight loss, with acute weight reduction from 5-6 days p.i. (Hayasaka et al., 2009). These 
observations suggest that high challenge dose of peripheral infection also induce early 
mortality like intracerebral infection and subcutaneous infection with highly virulent 
strains. 
3.1.4 Severe CNS infection contributes to early mortality 
Early mortality strongly correlates with acute and widespread neuronal degeneration due to 
viral cytopathic effects in the CNS (Hayasaka et al., 2009; Hayasaka et al., 2010). Following 
intracerebral infection with the Oshima strain, virus replication occurred almost 
simultaneously in peripheral and CNS organs. At day 6 p.i., viral load was significantly 
increased to more than 108 PFU/g of tissue in all regions of the CNS including the brain 
cortex, thalamus, cerebellum, brain stem and spinal cord (Hayasaka et al., 2010). 
Histopathological analysis corresponded well with the viral load, demonstrating acutely 
necrotic neurons and mild inflammation throughout the CNS, particularly in the brain 
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cortex, thalamus, cerebellum and lumber spinal cord. All degenerated cells examined were 
TBEV antigen-positive (Hayasaka et al., 2010).  
Subcutaneous infection with a high challenge dose of Oshima strain also showed early CNS 
infection at 1 day p.i., almost simultaneously with peripheral organ replication (Hayasaka et 
al., 2009). The viral load peaked in the CNS at 7 days p.i., and mice started to die at around 
the same period. Consistent with the viral load, histopathological examination showed acute 
necrotic neurons with TBEV antigens and inflammatory reactions throughout the CNS 
involving the brain cortex, thalamus, cerebellum, brainstem and spinal cord (Hayasaka et 
al., 2009). Furthermore, we showed that subcutaneous infection with low challenge dose of 
the Sofjin and IR strains also exhibited severe CNS infection in mice, indicating that even 
low dose challenges with these strains rapidly reach a lethal level (Hayasaka et al., 
unpublished data). 
These results strongly suggest that early death primarily results from acute neurological 
dysfunction throughout the CNS due to viral cytopathic effects, and mice showing clinical 
signs of illness subsequently die. Thus, CNS pathology is directly linked to lethality, and 
mortality rate is dose-dependent in TBEV infections with early mortality. 
3.2 Late mortality 
3.2.1 Peripheral inoculation with low virulent strain 
We previously showed that subcutaneous infection with a lower virus challenge dose (102 - 
106 PFU) of the TBEV Oshima strain resulted in 40 to 60% mortality without obvious 
difference in mortality rates at any of the challenge doses. Mice started to die after 11 days 
p.i. and the average of survival times were around 15-16 days p.i., irrespective of the 
challenge dose (Hayasaka et al., 2009).  
Interestingly, all low challenge doses (102 - 106 PFU) induced 100% morbidity and 100% 
infectivity as determined by weight loss and by TBEV-specific antibody positivity, 
respectively (Hayasaka et al., unpublished data). Furthermore, all brains infected with low 
challenge doses contained infectious virus at 9 to 11 days p.i., the period when mice 
exhibited weight loss (Hayasaka et al., 2009). These observations suggest that CNS 
pathology is not directly linked to lethality in TBEV infections with late mortality, and 
whether mice die or survive is determined at late stage of infection, independent of the 
challenge dose. 
3.2.2 Complex mechanism of CNS infection and immune response contribute to late 
mortality 
To examine the mechanism of late mortality in detail, we distinguished dying and 
recovering/surviving mice by their degree of weight loss following subcutaneous infection 
with low virus challenge doses of the Oshima strain (Hayasaka et al., 2009). Viral load in the 
CNS was not as high as intracerebral infection. Interestingly, viral load in the CNS was not 
significantly different between dying and recovering mice. Histopathological examination 
showed inflammatory reactions with focal proliferation of microglial rod cells in the brain 
cortex, thalamus, cerebellum, brainstem and spinal cord in both dying and recovering mice 
(Hayasaka et al., 2009). These observations suggest that following low challenge dose, mice 
develop encephalitis but also show features of virus clearance from the CNS. Furthermore, 
viral infection alone is not a critical determinant of late death, unlike that of early death 
(Hayasaka et al., 2009). 
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Inflammatory responses were assessed by measuring cell infiltration and inflammatory 
cytokine levels in brains (Hayasaka et al., 2009). Infiltrating leukocyte levels including CD8+ 
T cells, CD4+ T cells, neutrophils, natural killer cell and macrophages were significantly 
increased in TBEV-infected mice compared with mock-infected mice, but there were no 
significant differences between dying and recovering mice. Although the levels of 
inflammatory cytokines involving IFN-γ, IL-2, IL-5 and IL-10 in the brain were increased 
compared with mock-infected mice, there were no significant differences between dying 
and surviving mice either (Hayasaka et al., 2009). On the other hand, TNF-α levels were 
higher in dying mice than in recovering mice, suggesting that TNF-α response in the CNS 
correlates with severity. 
Thymocytes and splenocytes were dramatically decreased in dying mice compared with 
mock-infected and surviving mice. In addition, corticosterone was most significantly increased 
in dying mice. These observations suggest that dying mice exhibited a severe stress response. 
Serum levels of IFN-γ, RANTES and TNF-α were increased in both dying and recovering 
mice compared with mock-infected mice (Hayasaka et al., 2009). Interestingly, only serum 
TNF-α had significantly elevated levels in dying mice compared with surviving mice. 
Furthermore, among various cytokines examined, IL-10 expression was significantly 
increased in the spleen of dying mice compared with surviving and mock-infected mice 
(Hayasaka et al., unpublished data).  
These results suggest that fatality is determined by a complex mechanism of CNS pathology 
and systemic response that involve stress response and increased levels of TNF-α and IL-10. 
4. Conclusions 
The laboratory mouse model is commonly employed to study the CNS pathology of TBEV 
in vivo because mice develop neurological symptoms and relatively comparable 
neurological dysfunction similar to that observed in humans (Chiba et al., 1999a; Pogodina 
and Savinov, 1964; Sokol, Libikova, and Zemla, 1959; Vince and Grcevic, 1969). However, in 
the mouse model of encephalitic flavivirus infection, dose-independent mortality has been 
an unresolved problem since the 1940’s (King et al., 2007; Lennette, 1944). To explain its 
mechanism, we recently reported two distinct features of early and late mortality. Late 
death following low virus challenge doses appears to be a key feature of dose-independent 
mortality. Furthermore, we have shown that lethal levels of CNS infection cause early 
mortality, whereas immune and stress responses in addition to CNS infection contribute to 
late mortality (Hayasaka et al., 2009; Hayasaka et al., 2010). Importantly, whether mice show 
early or late mortality is associated with the infectious route, virus strain and inoculation 
dose (Fig. 3). 
It is generally believed that human cases succumb to acute and critical neuronal dysfunction 
following direct viral infection of the neurons, suggesting that early death, as shown in this 
mouse study, possibly relates to the mechanism of mortality in human cases. Thus, TBEV 
strains that induce early mortality following peripheral inoculation in mice can be 
considered as highly virulent and can cause severe disease in humans. Since far-eastern 
subtypes of TBEV cause more severe disease with up to 20-40% fatality rate in humans, they 
can be predicted to exhibit early mortality. Contradictory to this however, Oshima, KH and 
VL strains of Far-eastern subtype exhibit late mortality: infected mice had mild CNS 
infection and some of them recovered. On the other hand, Sofjin (Far-eastern subtype), 
Hochosterwitz (European-subtype) and IR strain (Siberian subtype) strains induce early 
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mortality following peripheral infection, indicating that these strains are potentially more 
virulent than Oshima, KH and VL strains. Thus, virulence is inconsistent with the TBEV 
subtype; rather, highly virulent types are more likely to be randomly distributed in endemic 
areas. In fact, recent studies suggest that seroprevalence rates differ in Europe (1–20%) and 
in Russia (30–100%), and thus the morbidity and mortality rates may be due to selective 
severe cases (Lindquist and Vapalahti, 2008).  
Our results showed that in addition to CNS infection, systemic stress and inflammatory 
responses in late phases potentially contribute to the severity and lethality of TBE in human 
cases. Further elucidation of this mechanism using the mouse model is an important priority 
to enable the development of effective treatment strategies for human TBE. 
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Fig. 3. Summary of early and late mortality observed following TBEV infection in mice 
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